Sponsors (2)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Creates a new federal entry titled "Chemical abortion risk awareness" in the Public Health Service Act but provides no substantive requirements, definitions, funding, or enforcement mechanisms. It also preserves state authority to require greater disclosure or penalties related to abortion and includes a severability clause so other provisions remain if any part is struck down.
The bill may increase patient information and preserve state control over abortion disclosure rules, but it also creates legal uncertainty and a state‑by‑state patchwork that could raise compliance costs and erect additional barriers to abortion care.
Women and other patients (including pregnant people) could receive more information about medication abortion risks, improving informed consent and decision‑making.
State governments retain authority to keep or enforce stricter abortion‑related disclosure rules and penalties, preserving state policy preferences and local control.
Healthcare providers, hospitals, and state governments will face legal uncertainty and a patchwork of obligations about disclosure and enforcement, increasing compliance costs and legal risk.
Women and pregnant people could face greater barriers or deterrents to obtaining abortion care if provisions are implemented with mandatory, stigmatizing disclosures or harsher penalties.
Confusion about which state disclosure requirements and penalties apply across state lines could complicate access to care and create administrative burdens for providers and states.
Introduced January 23, 2026 by Marlin A. Stutzman · Last progress January 23, 2026